ABVC logo

ABVC BioPharma (ABVC) Depreciation And Amortization

Annual D&A

$28.50 K
+$4700.00+19.75%

December 31, 2023

Summary

Performance

1-Year Change

+19.75%

3-Year Change

-23.18%

5-Year Change

-

15-Year Change

-

ABVC Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.66%
ABVC annual depreciation & amortization is higher than 6.66% of companies in Healthcare sector

High & Low

All-time High

$55.10 K
ABVC annual depreciation & amortization is currently -48.28% below its historical high of $55.10 thousand

3-Year Low

$12.00 K
ABVC annual depreciation & amortization is currently +137.50% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABVC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
ABVC next annual earnings announcement is scheduled for Mar 14, 2025

Related metrics

Annual Total Expenses

$8.37 M
ABVC annual total expenses is $8.37 million

Annual Operating Expenses

$8.07 M
ABVC annual total operating expenses is $8.07 million

Annual Cost Of Goods Sold

$302.00 K
ABVC annual cost of goods sold is $302.00 thousand

Annual Interest Expense

$2.49 M
ABVC annual interest expense is $2.49 million

Quarterly D&A

$7000.00
-$6300.00-47.37%

September 30, 2024

Summary

Performance

3-Month Change

-47.37%

1-Year Change

-6.67%

3-Year Change

+141.38%

5-Year Change

+141.38%

ABVC Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.98%
ABVC quarterly depreciation & amortization is higher than 8.98% of companies in Healthcare sector

High & Low

All-time High

$15.70 K
ABVC quarterly depreciation & amortization is currently -55.41% below its historical high of $15.70 thousand

3-Year Low

$1300.00
ABVC quarterly depreciation & amortization is currently +438.46% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABVC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ABVC next earnings announcement is scheduled for Mar 14, 2025

Related metrics

Quarterly Total Expenses

$339.30 K
ABVC quarterly total expenses is $339.30 thousand

Quarterly Operating Expenses

$339.00 K
ABVC quarterly total operating expenses is $339.00 thousand

Quarterly Cost Of Goods Sold

$300.00
ABVC quarterly cost of goods sold is $300.00

Quarterly Interest Expense

$219.50 K
ABVC quarterly interest expense is $219.50 thousand

TTM D&A

$29.20 K
-$500.00-1.68%

September 30, 2024

Summary

Performance

3-Month Change

-1.68%

1-Year Change

+6.57%

3-Year Change

+88.39%

5-Year Change

+88.39%

ABVC TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.59%
ABVC TTM depreciation & amortization is higher than 7.59% of companies in Healthcare sector

High & Low

All-time High

$55.10 K
ABVC TTM depreciation & amortization is currently -47.01% below its historical high of $55.10 thousand

3-Year Low

$12.00 K
ABVC TTM depreciation & amortization is currently +143.33% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABVC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ABVC next earnings announcement is scheduled for Mar 14, 2025

Related metrics

Annual Total Expenses

$8.37 M
ABVC annual total expenses is $8.37 million

Annual Operating Expenses

$8.07 M
ABVC annual total operating expenses is $8.07 million

TTM Cost Of Goods Sold

$140.00 K
ABVC TTM cost of goods sold is $140.00 thousand

TTM Interest Expense

$2.27 M
ABVC TTM interest expense is $2.27 million

ABVC Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.8%-6.7%+6.6%
3 y3 years-23.2%+141.4%+88.4%
5 y5 years-+141.4%+88.4%

ABVC Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+137.5%-47.4%+438.5%-1.7%+143.3%
5 y5-year-48.3%+137.5%-47.4%+438.5%-47.0%+143.3%
alltimeall time-48.3%+137.5%-55.4%+121.1%-47.0%-100.0%

ABVC BioPharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$7000.00(-47.4%)
$29.20 K(-1.7%)
Jun 2024
-
$13.30 K(+923.1%)
$29.70 K(+26.9%)
Mar 2024
-
$1300.00(-82.9%)
$23.40 K(-18.2%)
Dec 2023
$28.50 K(+19.7%)
$7600.00(+1.3%)
$28.60 K(+4.4%)
Sep 2023
-
$7500.00(+7.1%)
$27.40 K(+3.8%)
Jun 2023
-
$7000.00(+7.7%)
$26.40 K(+6.0%)
Mar 2023
-
$6500.00(+1.6%)
$24.90 K(+4.6%)
Dec 2022
$23.80 K(+98.3%)
$6400.00(-1.5%)
$23.80 K(+15.0%)
Sep 2022
-
$6500.00(+18.2%)
$20.70 K(+21.1%)
Jun 2022
-
$5500.00(+1.9%)
$17.10 K(+17.9%)
Mar 2022
-
$5400.00(+63.6%)
$14.50 K(+20.8%)
Dec 2021
$12.00 K(-67.7%)
$3300.00(+13.8%)
$12.00 K(-22.6%)
Sep 2021
-
$2900.00(0.0%)
$15.50 K(-27.2%)
Jun 2021
-
$2900.00(0.0%)
$21.30 K(-26.0%)
Mar 2021
-
$2900.00(-57.4%)
$28.80 K(-22.4%)
Dec 2020
$37.10 K(-32.7%)
$6800.00(-21.8%)
$37.10 K(-10.6%)
Sep 2020
-
$8700.00(-16.3%)
$41.50 K(-11.9%)
Jun 2020
-
$10.40 K(-7.1%)
$47.10 K(-10.1%)
Mar 2020
-
$11.20 K(0.0%)
$52.40 K(-4.9%)
Dec 2019
$55.10 K
$11.20 K(-21.7%)
$55.10 K(+415.0%)
Sep 2019
-
$14.30 K(-8.9%)
$10.70 K(+52.9%)
Jun 2019
-
$15.70 K(+12.9%)
$7000.00(+169.2%)
Mar 2019
-
$13.90 K(-141.9%)
$2600.00(+2500.0%)
Dec 2018
-
-$33.20 K(-413.2%)
$100.00(-99.7%)
Sep 2018
-
$10.60 K(-6.2%)
$33.30 K(+46.7%)
Jun 2018
-
$11.30 K(-0.9%)
$22.70 K(+99.1%)
Mar 2018
-
$11.40 K(>+9900.0%)
$11.40 K(>+9900.0%)
Jun 2015
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(-100.0%)
DateAnnualQuarterlyTTM
Mar 2014
-
$0.00(0.0%)
$8000.00(-50.0%)
Dec 2013
-
$0.00(0.0%)
$16.00 K(-33.3%)
Sep 2013
$23.90 K(-27.6%)
$0.00(-100.0%)
$24.00 K(-26.6%)
Jun 2013
-
$8000.00(0.0%)
$32.70 K(0.0%)
Mar 2013
-
$8000.00(0.0%)
$32.70 K(0.0%)
Dec 2012
-
$8000.00(-8.0%)
$32.70 K(-1.2%)
Sep 2012
$33.00 K(-3.5%)
$8700.00(+8.8%)
$33.10 K(+0.3%)
Jun 2012
-
$8000.00(0.0%)
$33.00 K(-0.9%)
Mar 2012
-
$8000.00(-4.8%)
$33.30 K(+2.1%)
Dec 2011
-
$8400.00(-2.3%)
$32.60 K(-4.7%)
Sep 2011
$34.20 K(-24.3%)
$8600.00(+3.6%)
$34.20 K(-6.8%)
Jun 2011
-
$8300.00(+13.7%)
$36.70 K(-7.8%)
Mar 2011
-
$7300.00(-27.0%)
$39.80 K(-9.8%)
Dec 2010
-
$10.00 K(-9.9%)
$44.10 K(-2.6%)
Sep 2010
$45.20 K(+0.2%)
$11.10 K(-2.6%)
$45.30 K(-0.7%)
Jun 2010
-
$11.40 K(-1.7%)
$45.60 K(0.0%)
Mar 2010
-
$11.60 K(+3.6%)
$45.60 K(+0.7%)
Dec 2009
-
$11.20 K(-1.8%)
$45.30 K(+0.4%)
Sep 2009
$45.10 K(+20.3%)
$11.40 K(0.0%)
$45.10 K(-0.2%)
Jun 2009
-
$11.40 K(+0.9%)
$45.20 K(+3.9%)
Mar 2009
-
$11.30 K(+2.7%)
$43.50 K(+3.8%)
Dec 2008
-
$11.00 K(-4.3%)
$41.90 K(+11.7%)
Sep 2008
$37.50 K(+193.0%)
$11.50 K(+18.6%)
$37.50 K(+44.2%)
Jun 2008
-
$9700.00(0.0%)
$26.00 K(+30.0%)
Mar 2008
-
$9700.00(+47.0%)
$20.00 K(+94.2%)
Dec 2007
-
$6600.00(+78.4%)
$10.30 K(+178.4%)
Sep 2007
$12.80 K
-
-
Jun 2007
-
$3700.00(-149.3%)
$3700.00(>+9900.0%)
Dec 2006
-
-$7500.00(-200.0%)
$0.00(-100.0%)
Sep 2006
-
$7500.00
$7500.00

FAQ

  • What is ABVC BioPharma annual depreciation & amortization?
  • What is the all time high annual D&A for ABVC BioPharma?
  • What is ABVC BioPharma annual D&A year-on-year change?
  • What is ABVC BioPharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for ABVC BioPharma?
  • What is ABVC BioPharma quarterly D&A year-on-year change?
  • What is ABVC BioPharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for ABVC BioPharma?
  • What is ABVC BioPharma TTM D&A year-on-year change?

What is ABVC BioPharma annual depreciation & amortization?

The current annual D&A of ABVC is $28.50 K

What is the all time high annual D&A for ABVC BioPharma?

ABVC BioPharma all-time high annual depreciation & amortization is $55.10 K

What is ABVC BioPharma annual D&A year-on-year change?

Over the past year, ABVC annual depreciation & amortization has changed by +$4700.00 (+19.75%)

What is ABVC BioPharma quarterly depreciation & amortization?

The current quarterly D&A of ABVC is $7000.00

What is the all time high quarterly D&A for ABVC BioPharma?

ABVC BioPharma all-time high quarterly depreciation & amortization is $15.70 K

What is ABVC BioPharma quarterly D&A year-on-year change?

Over the past year, ABVC quarterly depreciation & amortization has changed by -$500.00 (-6.67%)

What is ABVC BioPharma TTM depreciation & amortization?

The current TTM D&A of ABVC is $29.20 K

What is the all time high TTM D&A for ABVC BioPharma?

ABVC BioPharma all-time high TTM depreciation & amortization is $55.10 K

What is ABVC BioPharma TTM D&A year-on-year change?

Over the past year, ABVC TTM depreciation & amortization has changed by +$1800.00 (+6.57%)